Evidence map›Paper›PMID 2832731›Full record

ArticleMolecular and cellular biology1988

Mutational analysis of upstream activation sequence 2 of the CYC1 gene of Saccharomyces cerevisiae: a HAP2-HAP3-responsive site.

S L Forsburg, L Guarente

Abstract read
In one paragraph

Article in Molecular and cellular biology, 1988. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed.

  1. Genome-Wide Identification of thePlants (Basel, Switzerland) · 2025
    Article
  2. The Nuclear Transcription FactorInternational journal of molecular sciences · 2025
    Article
  3. Genomic identification of theMolecular breeding : new strategies in plant improvement · 2025
    Article
  4. Biology · 2021
    Review
  5. NovelInternational journal of molecular sciences · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S L ForsburgDepartment of Biology, Massachusetts Institute of Technology, Cambridge 02139.
L Guarente

Funding

MOLECULAR ANALYSIS OF TRANSCRIPTIONAL ACTIVATORS HAP1-4R01GM030454 · NIGMS · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GUARENTE, LEONARD P · 1985 to 1998
–
NIGMS NIH HHS 5 ROI GM30454-05
6 · The paper itself

Abstract

We analyzed upstream activation sequence 2 (UAS2), one of two independent UAS elements in the CYC1 gene of Saccharomyces cerevisiae. Deletions and linker scanning mutations across the 87 base pairs previously defined as UAS2 showed two separate functional elements required for full activity. Region 1, from -230 to -200, contains the principal activation site and responds to the trans-acting regulatory loci HAP2 and HAP3. A portion of region 1 is homologous to two other HAP2-HAP3-responsive UASs and includes the G----A transition mutation UP1, which increases UAS2 activity. This consensus sequence TNATTGGT bears striking similarity to several CAAT box sequences of higher cells. Region 2, from -192 to -178, substantially enhances the activity of region 1, yet has little activity by itself. These regions bind distinct proteins found in crudely fractionated yeast extracts.

Indexed as

Cytochromes cGene Expression RegulationGenesGenes, RegulatorSaccharomyces cerevisiae ProteinsTranscription, GeneticBase SequenceChromosome DeletionCytochrome c GroupPlasmidsSaccharomyces cerevisiaeCYC1 protein, S cerevisiaeCytochrome c GroupCytochromes cSaccharomyces cerevisiae Proteins

Identifiers

PMID2832731
PMCPMC363190

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.